Literature DB >> 27668763

Peripheral blood versus bone marrow transplant in patients with aplastic anemia, an unresolved issue.

A Ghavamzadeh1, K Alimoghaddam1, M Jalili1, S A Mousavi1, B Bahar1, A Kasaeian1,2, A A Hamidieh1, M Behfar1, M Vaezi1, A Jalali3, M Jahani1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27668763     DOI： 10.1038/bmt.2016.235

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  12 in total

1.  Gene expression profiling identifies significant differences between the molecular phenotypes of bone marrow-derived and circulating human CD34+ hematopoietic stem cells.

Authors:  Ulrich Steidl; Ralf Kronenwett; Ulrich-Peter Rohr; Roland Fenk; Slawomir Kliszewski; Christian Maercker; Peter Neubert; Manuel Aivado; Judith Koch; Olga Modlich; Hans Bojar; Norbert Gattermann; Rainer Haas
Journal:  Blood       Date:  2002-03-15       Impact factor: 22.113

Review 2.  Peripheral blood stem cell versus bone marrow allotransplantation: does the source of hematopoietic stem cells matter?

Authors:  M Körbling; P Anderlini
Journal:  Blood       Date:  2001-11-15       Impact factor: 22.113

3.  Guidelines for the diagnosis and management of acquired aplastic anaemia.

Authors:  J C W Marsh; S E Ball; P Darbyshire; E C Gordon-Smith; A J Keidan; A Martin; S R McCann; J Mercieca; D Oscier; A W W Roques; J A L Yin
Journal:  Br J Haematol       Date:  2003-12       Impact factor: 6.998

4.  Bone marrow versus peripheral blood as the stem cell source for sibling transplants in acquired aplastic anemia: survival advantage for bone marrow in all age groups.

Authors:  Andrea Bacigalupo; Gérard Socié; Hubert Schrezenmeier; Andre Tichelli; Anna Locasciulli; Monika Fuehrer; Antonio M Risitano; Carlo Dufour; Jakob R Passweg; Rosi Oneto; Mahmoud Aljurf; Catherine Flynn; Valerie Mialou; Rose Marie Hamladji; Judith C W Marsh
Journal:  Haematologica       Date:  2012-02-07       Impact factor: 9.941

5.  The epidemiology of acquired aplastic anemia.

Authors:  Neal S Young; David W Kaufman
Journal:  Haematologica       Date:  2008-04       Impact factor: 9.941

6.  Allogeneic bone marrow transplantation in the developing world: experience from a center in India.

Authors:  M Chandy; A Srivastava; D Dennison; V Mathews; B George
Journal:  Bone Marrow Transplant       Date:  2001-04       Impact factor: 5.483

Review 7.  Current concepts in the pathophysiology and treatment of aplastic anemia.

Authors:  Neal S Young; Rodrigo T Calado; Phillip Scheinberg
Journal:  Blood       Date:  2006-06-15       Impact factor: 22.113

8.  Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry.

Authors:  G Socié; J V Stone; J R Wingard; D Weisdorf; P J Henslee-Downey; C Bredeson; J Y Cahn; J R Passweg; P A Rowlings; H C Schouten; H J Kolb; J P Klein
Journal:  N Engl J Med       Date:  1999-07-01       Impact factor: 91.245

Review 9.  Aplastic anemia: therapeutic updates in immunosuppression and transplantation.

Authors:  Phillip Scheinberg
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2012

Review 10.  Current status of allogeneic bone marrow transplantation in acquired aplastic anemia.

Authors:  M M Horowitz
Journal:  Semin Hematol       Date:  2000-01       Impact factor: 3.851
View more
  1 in total

1.  Aplastic Anemia Preconditioned with Fludarabine, Cyclophosphamide, and Anti-Thymocyte Globulin.

Authors:  Dan Yang; Jianmin Yang; Xiaoxia Hu; Jie Chen; Lei Gao; Hui Cheng; Gusheng Tang; Yanrong Luo; Weiping Zhang; Jianmin Wang
Journal:  Ann Transplant       Date:  2019-08-09       Impact factor: 1.530
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.